Results 121 to 130 of about 70,790 (271)

TNF-Inhibition With Etanercept For GVHD Prevention In Alternative Donor HCT: Lower TNFR1 Levels Correlate With Better Outcomes [PDF]

, 2010
Sung Won Choi, Patrick J. Stiff, Thomas Braun, James L.M. Ferrara, Kenneth R. Cooke, Y. Khaled, Carrie L. Kitko, Jennifer Lay-Luskin, Shin Mineishi, B J Nickoloff, Sophie Paczesny, Attaphol Pawarode, E. Peres, Pavan Reddy, Julia Richardson, Tulio E. Rodriguez, Scott E. Smith, Gregory A. Yanik, Joel Whitfield, John E. Levine   +19 more
openalex   +1 more source

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Weiyu Ye, Niamh Dooley, Wei Ren Tan, Bolaji Coker, Teresa Tsakok, Lucy Moorhead, Jade Pizzato, Kingsley Powell, Madeline Kroah‐Hartman, Alexandra Paolino, Treasa Jiang, Freya Jackson‐Duffy, John Y. W. Lee, Manpreet K. Sagoo, Georgia Sewell, Camille Lancelot, Helen McAteer, John Weinman, Jonathan N. Barker, Sarah Chapman, Sam Norton, Catherine H. Smith, Satveer K. Mahil   +22 more
wiley   +1 more source

Optimized ACE2‐Fc fusion proteins with picomolar neutralization activity against highly evolved SARS‐CoV‐2 variants

Protein Science, Volume 35, Issue 2, February 2026.
Abstract The rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has compromised the efficacy of many authorized monoclonal antibody products. This highlights the need for alternative strategies, especially for vulnerable populations such as immunocompromised individuals.
Ferran Abancó, Ferran Tarrés‐Freixas, Rosalba Lepore, Elisa Molina‐Molina, Eloi Franco, Rytis Boreika, Edwards Pradenas, Dàlia Raïch‐Regué, Itziar Erkizia, Bonaventura Clotet, Alfonso Valencia, Júlia Vergara‐Alert, Joaquim Segalés, Jorge Carrillo, Nuria Izquierdo‐Useros, Julià Blanco, Benjamin Trinité   +16 more
wiley   +1 more source

TNF Inhibitor‐Induced Sarcoidosis‐Like Lesions in Inflammatory Bowel Disease

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background While tumor necrosis factor (TNF) inhibitors can induce paradoxical reactions, sarcoidosis‐like disease has hardly been reported so far. This study aimed to describe the epidemiological, diagnostic and therapeutic features of TNF inhibitor‐induced sarcoidosis‐like lesions in patients with inflammatory bowel disease.
Zlata Chkolnaia, Benedicte Lebrun‐Vignes, Aurelien Amiot, Mathieu Uzzan, Nicolas Richard, Maeva Charkaoui, Guillaume Le Cosquer, Carmen Stefanescu, Melanie Serrero, Laurianne Plastaras, Sophie Vieujean, David Laharie, Philippe Seksik   +12 more
wiley   +1 more source

Unexpected multiple sclerosis‐like symptoms in a rheumatoid arthritis patient treated with Etanercept: A case report

Clinical Case Reports
Key Clinical Massage Although tumor necrosis factor (TNF) inhibitors are used to prevent autoimmune disease, but they can cause adverse effects. Multiple sclerosis syndrome is one of the rare complications following treatment with TNF inhibitor.
Ali Hosseinpour, Arsh Haj Mohamad Ebrahim Ketabforoush, Elnaz Daneshzad, Ali Babanezhad Gajouti, Samaneh Hajimollarabi   +4 more
doaj   +1 more source

Tuberculous tonsillitis in a patient receiving etanercept treatment [PDF]

, 2003
Chris T. Derk, R J DeHoratius
openalex   +1 more source

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.

New England Journal of Medicine, 2000
J. Bathon, Richard W. Martin, R. Fleischmann, J. Tesser, M. Schiff, E. Keystone, M. Genovese, M. Wasko, L. Moreland, A. Weaver, J. Markenson, B. Finck   +11 more
semanticscholar   +1 more source

Using etanercept to maintain remission of psoriatic arthritis during pregnancy

, 2014
Ibrahim A. Al-Homood, Mansour Somaily
openalex   +1 more source

Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response [PDF]

, 2023
Philippa D. K. Curry, Andrew P. Morris, Meghna Jani, Hector Chinoy, Anne Barton, James Bluett, James Bluett, E G Chelliah, C Chattopadhyay, Pauline Ho, Anne Barton, Madhura Castelino, Ian N Bruce, Rachel Gorodkin, Kimme L Hyrich, Ben Parker, Hector Chinoy, Terri E. O’Neil, Ariane L. Herrick, Anthony Jones, Robert G. Cooper, William G Dixon, Beverley Harrison, Meghna Jani, Andrea Low, Eleanor Korendowych, Neil McHugh, William Tillett, Nicola Goodson, Suzanne Lane, L Shand, Ira Pande, Ian Gaywood, Frances Rees, Megan Rutter, S. Hayat, J F McHale, A C Jones, Peter Lanyon, Anil K. Gupta, P A Courtney, A Srikanth, Abhishek Abhishek, Stuart Kyle, R Manhas, Anupama Nandagudi, Easter S. Suviseshamuthu, A. Bharadwaj, Nagui Gendi, Randa Alshakh, Saima Naz, Mohammad Kaleem Ahmad, Lena Das, M Pattrick, A P Bowden, Eric E. Smith, P S Klimiuk, D J Speden, Marwan Bukhari, Svetlana Kavaklieva, L Ottewell, Marco Massarotti, Jon Packham, Pippa Watson, Paul W. Sanders, S. Haque, Bhupinder Pal, Ellen Bruce, Z Karim, K. Mackay, Holly A. Shiels, John Taylor, Rachel Jeffery, Pradip Nandi, Charlotte Filer, Abbas Ismail, Louise Mercer, A. Hassan, Alistair B. Russell, M Durrani, W Hassan, A Samanta, P Sheldon, James N. Francis, Alison Kinder, R Neame, Arumugam Moorthy, Stefano Bombardieri, S. Kelly, Justin T. Maxwell, Mohamed Akil, Simon Till, Lisa Dunkley, Rachel Tattersall, Rachael Kilding, T Tait, K-P Kuet, Barth D. Grant, M Kazmi, D. Graham   +99 more
openalex   +1 more source

Etanercept (Enbrel®) alternative storage at ambient temperature

Clinical Pharmacology: Advances and Applications, 2017
Edel Shannon,1 Joanne Daffy,2 Heather Jones,3 Andrea Paulson,4 Steven M Vicik5 1Global Chemistry, Manufacturing, and Controls Regulatory, 2Contract Operations Quality Assurance, Pfizer Ireland Pharmaceuticals, Clondalkin, Dublin, Ireland; 3Medical ...
Shannon E, Daffy J, Jones H, Paulson A, Vicik SM   +4 more
doaj